926PErdafitinib (erda) versus available therapies in...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

926PErdafitinib (erda) versus available therapies in advanced urothelial cancer: A matching adjusted indirect comparison

Loriot, Y, Van Sanden, S, Diels, J, Rahhali, N, Seshagiri, D, Kowalski, B, Fleming, S, De Porre, P, Siefker-Radtke, A O
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.025
Date:
October, 2019
File:
PDF, 88 KB
2019
Conversion to is in progress
Conversion to is failed